Dr. Lustberg joined the Division of Solid Tumor Oncology in 2008. Her research interests include the development of novel blood biomarkers and treatment-related toxicity and survivorship. As part of fellowship training she completed a Breast Fellowship specifically designed to train future clinical translational investigators; she also completed a MPH in clinical investigation and received an ASCO Young Investigator Award. Her efforts in the lab are focused on the characterization of circulating tumor cells and the development of novel techniques to measure them. She also has been awarded grants from Alliance to support a randomized placebo-controlled trial of omega-3 fatty acids in the prevention of aromatase-related joint pains, and grants from Pelotonia and the Clinical Science Translational Center to support mouse models a chemotherapy-induced cognitive dysfunction (or “chemo brain) and clinical trials to find new drugs that will prevent or lessen “chemo brain.” In addition, she directs the Breast Cancer Survivorship Program at the Stefanie Spielman Comprehensive Breast Center and is member of Neuropathy Guidelines Committee for Adult Survivors. Dr. Lustberg provides clinical care to women with all stages of invasive breast cancer.